Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 11, 243 - 244 (2005)
doi:10.1038/nm0305-243
News Feature: A crucial test
Erika Check1
- Erika Check covers biomedical research for Nature magazine.
Companies are racing to take therapies using RNA interference into clinical trials. Erika Check appraises the front runners—and the safety concerns that could hobble them.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
